Sughrue Attorneys Lead ABA Program on Biosimilars

Sughrue attorneys, Kenneth Burchfiel, Michael Dzwonczyk and William Simmons, Ph.D., will participate in an ABA live webcast on the topic of Biosimilars today, June 29, 2010 at 1:00 p.m. EST. Biosimilars are of tremendous interest globally. It has been predicted that in the near future biologic therapies will amount to more than 50% of newly approved medicines. In the same period, a substantial number of patent protected biotechnology-based therapies will come off patent, enabling the marketing of biosimilar or follow on biologic products.

Even though opportunities abound, biosimilar producers and patients face risks, requiring producers to develop innovative legal strategies and to carefully assess research and development and production processes to guarantee safety and efficacy of biosimilar products to establish an efficient and safe strategy for biosimilar approval.

This discussion will explore the new US Biosimilars Pathway. For more information on this webcast, please visit